Published in Hepatitis Weekly, September 30th, 1996
Primary human hepatitis B virus (HBV) infections usually resolve within 6 months, but persistent infection occurs in 6-10 percent of cases.
These chronic carriers have a significant risk of developing cirrhosis and/or hepatocellular carcinoma. An effective treatment has yet to be realized, said Drs. Richard Colonno, and Robert Zahler at a presentation to the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting, held in New Orleans, Louisiana, September 15-18, 1996.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.